Programme At-a-glance
ILCA 15th Annual Conference Scientific Programme
The ILCA AC 2021 scientific programme will offer to participants with a large of different sessions dedicated to better prevent and treat liver cancer.
Scientific and medical experts from around the world will exchange the latest scientific advances and best practices in liver cancer research and care.
The 15th multidisciplinary Annual Conference format will present a mix of scientific and educational session and live debates and presentations.
Thursday September 2, 2021
September 2, 2021 | |
---|---|
14:00 - 14:15 | Welcome Address 14:00 14:15 Welcome Address Speaker: Bruno Sangro |
14:15 - 14:30 | Pre-conference workshop: Rare liver tumors 14:15 15:30 Pre-conference workshop: Rare liver tumors Moderators: Ghassan K. Abou-Alfa, Jessica Zucman-Rossi
Fibrolamellar Carcinoma Cholangio Mix Tumor
Hepatoblastoma |
14:30 - 14:45 | |
14:45 - 15:00 | |
15:00 - 15:15 | |
15:15 - 15:30 | |
15:30 - 15:45 | Break 15:30 15:45 |
15:45 - 16:00 | Pre-conference workshop: Rare liver tumors 15:45 16:30 Pre-conference workshop: Rare liver tumors Rare hepatic Tumors Patient Advocacy Questions & Answers |
16:00 - 16:15 | |
16:15 - 16:30 | |
16:30 - 16:45 | Break 16:30 16:45 |
16:45 - 17:00 | Single Topic Workshop 16:45 17:45 |
17:00 - 17:15 | |
17:15 - 17:30 | |
17:30 - 17:45 | |
17:45 - 18:00 | ILCA / EASL Symposium 17:45 18:30 |
18:00 - 18:15 | |
18:15 - 18:30 | |
18:30 - 18:45 | Industry Symposium 18:30 19:30 |
18:45 - 19:00 | |
19:00 - 19:15 | |
19:15 - 19:30 |
September 2, 2021
-
Welcome Address14:00 - 14:15
-
Pre-conference workshop:
Rare liver tumors14:15 - 15:30 -
Break15:30 - 15:45
-
Pre-conference workshop:
Rare liver tumors15:45 - 16:30 -
Break16:30 - 16:45
-
Single Topic Workshop16:45 - 17:45
-
ILCA / EASL Symposium17:45 - 18:30
-
Industry Symposium18:30 - 19:30
September 2, 2021 | |
---|---|
05:00 - 05:15 | Welcome Address 05:00 05:15 Welcome Address Speaker: Bruno Sangro |
05:15 - 05:30 | Pre-conference workshop: Rare liver tumors 05:15 06:30 Pre-conference workshop: Rare liver tumors Moderators: Ghassan K. Abou-Alfa, Jessica Zucman-Rossi
Fibrolamellar Carcinoma Cholangio Mix Tumor
Hepatoblastoma |
05:30 - 05:45 | |
05:45 - 06:00 | |
06:00 - 06:15 | |
06:15 - 06:30 | |
06:30 - 06:45 | Break 06:30 06:45 |
06:45 - 07:00 | Pre-conference workshop: Rare liver tumors 06:45 07:30 Pre-conference workshop: Rare liver tumors Rare hepatic Tumors Patient Advocacy Questions & Answers |
07:00 - 07:15 | |
07:15 - 07:30 | |
07:30 - 07:45 | Break 07:30 07:45 |
07:45 - 08:00 | Single Topic Workshop 07:45 08:45 |
08:00 - 08:15 | |
08:15 - 08:30 | |
08:30 - 08:45 | |
08:45 - 09:00 | ILCA / EASL Symposium 08:45 09:30 |
09:00 - 09:15 | |
09:15 - 09:30 | |
09:30 - 09:45 | Industry Symposium 09:30 10:30 |
09:45 - 10:00 | |
10:00 - 10:15 | |
10:15 - 10:30 |
September 2, 2021
-
Welcome Address05:00 - 05:15
-
Pre-conference workshop:
Rare liver tumors05:15 - 06:30 -
Break06:30 - 06:45
-
Pre-conference workshop:
Rare liver tumors06:45 - 07:30 -
Break07:30 - 07:45
-
Single Topic Workshop07:45 - 08:45
-
ILCA / EASL Symposium08:45 - 09:30
-
Industry Symposium09:30 - 10:30
September 2, 2021 | |
---|---|
08:00 - 08:15 | Welcome Address 08:00 08:15 Welcome Address Speaker: Bruno Sangro |
08:15 - 08:30 | Pre-conference workshop: Rare liver tumors 08:15 09:30 Pre-conference workshop: Rare liver tumors Moderators: Ghassan K. Abou-Alfa, Jessica Zucman-Rossi
Fibrolamellar Carcinoma Cholangio Mix Tumor
Hepatoblastoma |
08:30 - 08:45 | |
08:45 - 09:00 | |
09:00 - 09:15 | |
09:15 - 09:30 | |
09:30 - 09:45 | Break 09:30 09:45 |
09:45 - 10:00 | Pre-conference workshop: Rare liver tumors 09:45 10:30 Pre-conference workshop: Rare liver tumors Rare hepatic Tumors Patient Advocacy Questions & Answers |
10:00 - 10:15 | |
10:15 - 10:30 | |
10:30 - 10:45 | Break 10:30 10:45 |
10:45 - 11:00 | Single Topic Workshop 10:45 11:45 |
11:00 - 11:15 | |
11:15 - 11:30 | |
11:30 - 11:45 | |
11:45 - 12:00 | ILCA / EASL Symposium 11:45 12:30 |
12:00 - 12:15 | |
12:15 - 12:30 | |
12:30 - 12:45 | Industry Symposium 12:30 13:30 |
12:45 - 13:00 | |
13:00 - 13:15 | |
13:15 - 13:30 |
September 2, 2021
-
Welcome Address08:00 - 08:15
-
Pre-conference workshop:
Rare liver tumors08:15 - 09:30 -
Break09:30 - 09:45
-
Pre-conference workshop:
Rare liver tumors09:45 - 10:30 -
Break10:30 - 10:45
-
Single Topic Workshop10:45 - 11:45
-
ILCA / EASL Symposium11:45 - 12:30
-
Industry Symposium12:30 - 13:30
September 2, 2021 | |
---|---|
20:00 - 20:15 | Welcome Address 20:00 20:15 Welcome Address Speaker: Bruno Sangro |
20:15 - 20:30 | Pre-conference workshop: Rare liver tumors 20:15 21:30 Pre-conference workshop: Rare liver tumors Moderators: Ghassan K. Abou-Alfa, Jessica Zucman-Rossi
Fibrolamellar Carcinoma Cholangio Mix Tumor
Hepatoblastoma |
20:30 - 20:45 | |
20:45 - 21:00 | |
21:00 - 21:15 | |
21:15 - 21:30 | |
21:30 - 21:45 | Break 21:30 21:45 |
21:45 - 22:00 | Pre-conference workshop: Rare liver tumors 21:45 22:30 Pre-conference workshop: Rare liver tumors Rare hepatic Tumors Patient Advocacy Questions & Answers |
22:00 - 22:15 | |
22:15 - 22:30 | |
22:30 - 22:45 | Break 22:30 22:45 |
22:45 - 23:00 | Single Topic Workshop 22:45 23:45 |
23:00 - 23:15 | |
23:15 - 23:30 | |
23:30 - 23:45 | |
23:45 - 00:00 | ILCA / EASL Symposium 23:45 00:30 |
00:00 - 00:15 | |
00:15 - 00:30 |
September 2, 2021
-
Welcome Address20:00 - 20:15
-
Pre-conference workshop:
Rare liver tumors20:15 - 21:30 -
Break21:30 - 21:45
-
Pre-conference workshop:
Rare liver tumors21:45 - 22:30 -
Break22:30 - 22:45
-
Single Topic Workshop22:45 - 23:45
-
ILCA / EASL Symposium23:45 - 00:30
September 2, 2021 | |
---|---|
00:30 - 00:45 | Industry Symposium 00:30 01:30 |
00:45 - 01:00 | |
01:00 - 01:15 | |
01:15 - 01:30 |
September 2, 2021
-
Industry Symposium00:30 - 01:30
Friday September 3, 2021
September 3, 2021 | |
---|---|
13:45 - 14:00 | Daily wrap up 13:45 14:00 |
14:00 - 14:15 | Industry Symposium 14:00 15:00 |
14:15 - 14:30 | |
14:30 - 14:45 | |
14:45 - 15:00 | |
15:00 - 15:15 | Basic State of the Art 15:00 15:30 Basic State of the Art Telomeres and Cancer - Maria Blasco |
15:15 - 15:30 | |
15:30 - 15:45 | Break 15:30 15:45 |
15:45 - 16:00 | Young Investigator Session 15:45 16:45 |
16:00 - 16:15 | |
16:15 - 16:30 | |
16:30 - 16:45 | |
16:45 - 17:00 | Break 16:45 17:00 |
17:00 - 17:15 | Best Basic / Translational Poster session 17:00 18:00 |
17:15 - 17:30 | |
17:30 - 17:45 | |
17:45 - 18:00 | |
18:00 - 18:15 | Break 18:00 18:15 |
18:15 - 18:30 | Presidential Address & Junior Investigator Awards 18:15 18:45 |
18:30 - 18:45 | |
18:45 - 19:00 | Basic Science Symposium: What has single cell genomics contributed to our understanding of liver cancer? 18:45 19:30 Basic Science Symposium: What has single cell genomics contributed to our understanding of liver cancer? Chairs: Robert T. Schwabe, Amaia Lujambio
Single cell genomics and response to therapies in hepatocellular carcinoma - Xin Wei Wang, NIH |
19:00 - 19:15 | |
19:15 - 19:30 | |
19:30 - 19:45 | Industry Symposium 19:30 20:30 |
19:45 - 20:00 | |
20:00 - 20:15 | |
20:15 - 20:30 |
September 3, 2021
-
Daily wrap up13:45 - 14:00
-
Industry Symposium14:00 - 15:00
-
Basic State of the Art15:00 - 15:30
-
Break15:30 - 15:45
-
Young Investigator Session15:45 - 16:45
-
Break16:45 - 17:00
-
Best Basic / Translational Poster session17:00 - 18:00
-
Break18:00 - 18:15
-
Presidential Address & Junior Investigator Awards18:15 - 18:45
-
Basic Science Symposium:
What has single cell genomics contributed to our understanding of liver cancer?18:45 - 19:30 -
Industry Symposium19:30 - 20:30
September 3, 2021 | |
---|---|
04:45 - 05:00 | Daily wrap up 04:45 05:00 |
05:00 - 05:15 | Industry Symposium 05:00 06:00 |
05:15 - 05:30 | |
05:30 - 05:45 | |
05:45 - 06:00 | |
06:00 - 06:15 | Basic State of the Art 06:00 06:30 Basic State of the Art Telomeres and Cancer - Maria Blasco |
06:15 - 06:30 | |
06:30 - 06:45 | Break 06:30 06:45 |
06:45 - 07:00 | Young Investigator Session 06:45 07:45 |
07:00 - 07:15 | |
07:15 - 07:30 | |
07:30 - 07:45 | |
07:45 - 08:00 | Break 07:45 08:00 |
08:00 - 08:15 | Best Basic / Translational Poster session 08:00 09:00 |
08:15 - 08:30 | |
08:30 - 08:45 | |
08:45 - 09:00 | |
09:00 - 09:15 | Break 09:00 09:15 |
09:15 - 09:30 | Presidential Address & Junior Investigator Awards 09:15 09:45 |
09:30 - 09:45 | |
09:45 - 10:00 | Basic Science Symposium: What has single cell genomics contributed to our understanding of liver cancer? 09:45 10:30 Basic Science Symposium: What has single cell genomics contributed to our understanding of liver cancer? Chairs: Robert T. Schwabe, Amaia Lujambio
Single cell genomics and response to therapies in hepatocellular carcinoma - Xin Wei Wang, NIH |
10:00 - 10:15 | |
10:15 - 10:30 | |
10:30 - 10:45 | Industry Symposium 10:30 11:30 |
10:45 - 11:00 | |
11:00 - 11:15 | |
11:15 - 11:30 |
September 3, 2021
-
Daily wrap up04:45 - 05:00
-
Industry Symposium05:00 - 06:00
-
Basic State of the Art06:00 - 06:30
-
Break06:30 - 06:45
-
Young Investigator Session06:45 - 07:45
-
Break07:45 - 08:00
-
Best Basic / Translational Poster session08:00 - 09:00
-
Break09:00 - 09:15
-
Presidential Address & Junior Investigator Awards09:15 - 09:45
-
Basic Science Symposium:
What has single cell genomics contributed to our understanding of liver cancer?09:45 - 10:30 -
Industry Symposium10:30 - 11:30
September 3, 2021 | |
---|---|
07:45 - 08:00 | Daily wrap up 07:45 08:00 |
08:00 - 08:15 | Industry Symposium 08:00 09:00 |
08:15 - 08:30 | |
08:30 - 08:45 | |
08:45 - 09:00 | |
09:00 - 09:15 | Basic State of the Art 09:00 09:30 Basic State of the Art Telomeres and Cancer - Maria Blasco |
09:15 - 09:30 | |
09:30 - 09:45 | Break 09:30 09:45 |
09:45 - 10:00 | Young Investigator Session 09:45 10:45 |
10:00 - 10:15 | |
10:15 - 10:30 | |
10:30 - 10:45 | |
10:45 - 11:00 | Break 10:45 11:00 |
11:00 - 11:15 | Best Basic / Translational Poster session 11:00 12:00 |
11:15 - 11:30 | |
11:30 - 11:45 | |
11:45 - 12:00 | |
12:00 - 12:15 | Break 12:00 12:15 |
12:15 - 12:30 | Presidential Address & Junior Investigator Awards 12:15 12:45 |
12:30 - 12:45 | |
12:45 - 13:00 | Basic Science Symposium: What has single cell genomics contributed to our understanding of liver cancer? 12:45 13:30 Basic Science Symposium: What has single cell genomics contributed to our understanding of liver cancer? Chairs: Robert T. Schwabe, Amaia Lujambio
Single cell genomics and response to therapies in hepatocellular carcinoma - Xin Wei Wang, NIH |
13:00 - 13:15 | |
13:15 - 13:30 | |
13:30 - 13:45 | Industry Symposium 13:30 14:30 |
13:45 - 14:00 | |
14:00 - 14:15 | |
14:15 - 14:30 |
September 3, 2021
-
Daily wrap up07:45 - 08:00
-
Industry Symposium08:00 - 09:00
-
Basic State of the Art09:00 - 09:30
-
Break09:30 - 09:45
-
Young Investigator Session09:45 - 10:45
-
Break10:45 - 11:00
-
Best Basic / Translational Poster session11:00 - 12:00
-
Break12:00 - 12:15
-
Presidential Address & Junior Investigator Awards12:15 - 12:45
-
Basic Science Symposium:
What has single cell genomics contributed to our understanding of liver cancer?12:45 - 13:30 -
Industry Symposium13:30 - 14:30
September 3, 2021 | |
---|---|
19:45 - 20:00 | Daily wrap up 19:45 20:00 |
20:00 - 20:15 | Industry Symposium 20:00 21:00 |
20:15 - 20:30 | |
20:30 - 20:45 | |
20:45 - 21:00 | |
21:00 - 21:15 | Basic State of the Art 21:00 21:30 Basic State of the Art Telomeres and Cancer - Maria Blasco |
21:15 - 21:30 | |
21:30 - 21:45 | Break 21:30 21:45 |
21:45 - 22:00 | Young Investigator Session 21:45 22:45 |
22:00 - 22:15 | |
22:15 - 22:30 | |
22:30 - 22:45 | |
22:45 - 23:00 | Break 22:45 23:00 |
23:00 - 23:15 | Best Basic / Translational Poster session 23:00 00:00 |
23:15 - 23:30 | |
23:30 - 23:45 | |
23:45 - 00:00 | |
00:00 - 00:15 | Break 00:00 00:15 |
September 3, 2021
-
Daily wrap up19:45 - 20:00
-
Industry Symposium20:00 - 21:00
-
Basic State of the Art21:00 - 21:30
-
Break21:30 - 21:45
-
Young Investigator Session21:45 - 22:45
-
Break22:45 - 23:00
-
Best Basic / Translational Poster session23:00 - 00:00
-
Break00:00 - 00:15
September 3, 2021 | |
---|---|
00:15 - 00:30 | Presidential Address & Junior Investigator Awards 00:15 00:45 |
00:30 - 00:45 | |
00:45 - 01:00 | Basic Science Symposium: What has single cell genomics contributed to our understanding of liver cancer? 00:45 01:30 Basic Science Symposium: What has single cell genomics contributed to our understanding of liver cancer? Chairs: Robert T. Schwabe, Amaia Lujambio
Single cell genomics and response to therapies in hepatocellular carcinoma - Xin Wei Wang, NIH |
01:00 - 01:15 | |
01:15 - 01:30 | |
01:30 - 01:45 | Industry Symposium 01:30 02:30 |
01:45 - 02:00 | |
02:00 - 02:15 | |
02:15 - 02:30 |
September 3, 2021
-
Presidential Address & Junior Investigator Awards00:15 - 00:45
-
Basic Science Symposium:
What has single cell genomics contributed to our understanding of liver cancer?00:45 - 01:30 -
Industry Symposium01:30 - 02:30
Saturday September 4, 2021
September 4, 2021 | |
---|---|
13:45 - 14:00 | Daily wrap up 13:45 14:00 |
14:00 - 14:15 | Industry Symposium 14:00 15:00 |
14:15 - 14:30 | |
14:30 - 14:45 | |
14:45 - 15:00 | |
15:00 - 15:15 | General Session 1: Molecular Pathogenesis, Cell Biology and Translational Research 15:00 16:00 |
15:15 - 15:30 | |
15:30 - 15:45 | |
15:45 - 16:00 | |
16:00 - 16:15 | Break 16:00 16:15 |
16:15 - 16:30 | Clinical State of the Art 16:15 16:45 Clinical State of the Art Past, present, and future of transplant oncology - Vincenzo Mazaferro |
16:30 - 16:45 | |
16:45 - 17:00 | Break 16:45 17:00 |
17:00 - 17:15 | Best Clinical Poster session 17:00 18:00 |
17:15 - 17:30 | |
17:30 - 17:45 | |
17:45 - 18:00 | |
18:00 - 18:15 | Break 18:00 18:15 |
18:15 - 18:30 | ILCA Tumor Board 18:15 19:00 ILCA Tumor Board Chair: Pierre Nahon |
18:30 - 18:45 | |
18:45 - 19:00 | |
19:00 - 19:15 | General Session 2: Epidemiology, Staging and Prognosis 19:00 20:30 |
19:15 - 19:30 | |
19:30 - 19:45 | |
19:45 - 20:00 | |
20:00 - 20:15 | |
20:15 - 20:30 |
September 4, 2021
-
Daily wrap up13:45 - 14:00
-
Industry Symposium14:00 - 15:00
-
General Session 1:
Molecular Pathogenesis, Cell Biology and Translational Research15:00 - 16:00 -
Break16:00 - 16:15
-
Clinical State of the Art16:15 - 16:45
-
Break16:45 - 17:00
-
Best Clinical Poster session17:00 - 18:00
-
Break18:00 - 18:15
-
ILCA Tumor Board18:15 - 19:00
-
General Session 2:
Epidemiology, Staging and Prognosis19:00 - 20:30
September 4, 2021 | |
---|---|
04:45 - 05:00 | Daily wrap up 04:45 05:00 |
05:00 - 05:15 | Industry Symposium 05:00 06:00 |
05:15 - 05:30 | |
05:30 - 05:45 | |
05:45 - 06:00 | |
06:00 - 06:15 | General Session 1: Molecular Pathogenesis, Cell Biology and Translational Research 06:00 07:00 |
06:15 - 06:30 | |
06:30 - 06:45 | |
06:45 - 07:00 | |
07:00 - 07:15 | Break 07:00 07:15 |
07:15 - 07:30 | Clinical State of the Art 07:15 07:45 Clinical State of the Art Past, present, and future of transplant oncology - Vincenzo Mazaferro |
07:30 - 07:45 | |
07:45 - 08:00 | Break 07:45 08:00 |
08:00 - 08:15 | Best Clinical Poster session 08:00 09:00 |
08:15 - 08:30 | |
08:30 - 08:45 | |
08:45 - 09:00 | |
09:00 - 09:15 | Break 09:00 09:15 |
09:15 - 09:30 | ILCA Tumor Board 09:15 10:00 ILCA Tumor Board Chair: Pierre Nahon |
09:30 - 09:45 | |
09:45 - 10:00 | |
10:00 - 10:15 | General Session 2: Epidemiology, Staging and Prognosis 10:00 11:30 |
10:15 - 10:30 | |
10:30 - 10:45 | |
10:45 - 11:00 | |
11:00 - 11:15 | |
11:15 - 11:30 |
September 4, 2021
-
Daily wrap up04:45 - 05:00
-
Industry Symposium05:00 - 06:00
-
General Session 1:
Molecular Pathogenesis, Cell Biology and Translational Research06:00 - 07:00 -
Break07:00 - 07:15
-
Clinical State of the Art07:15 - 07:45
-
Break07:45 - 08:00
-
Best Clinical Poster session08:00 - 09:00
-
Break09:00 - 09:15
-
ILCA Tumor Board09:15 - 10:00
-
General Session 2:
Epidemiology, Staging and Prognosis10:00 - 11:30
September 4, 2021 | |
---|---|
07:45 - 08:00 | Daily wrap up 07:45 08:00 |
08:00 - 08:15 | Industry Symposium 08:00 09:00 |
08:15 - 08:30 | |
08:30 - 08:45 | |
08:45 - 09:00 | |
09:00 - 09:15 | General Session 1: Molecular Pathogenesis, Cell Biology and Translational Research 09:00 10:00 |
09:15 - 09:30 | |
09:30 - 09:45 | |
09:45 - 10:00 | |
10:00 - 10:15 | Break 10:00 10:15 |
10:15 - 10:30 | Clinical State of the Art 10:15 10:45 Clinical State of the Art Past, present, and future of transplant oncology - Vincenzo Mazaferro |
10:30 - 10:45 | |
10:45 - 11:00 | Break 10:45 11:00 |
11:00 - 11:15 | Best Clinical Poster session 11:00 12:00 |
11:15 - 11:30 | |
11:30 - 11:45 | |
11:45 - 12:00 | |
12:00 - 12:15 | Break 12:00 12:15 |
12:15 - 12:30 | ILCA Tumor Board 12:15 13:00 ILCA Tumor Board Chair: Pierre Nahon |
12:30 - 12:45 | |
12:45 - 13:00 | |
13:00 - 13:15 | General Session 2: Epidemiology, Staging and Prognosis 13:00 14:30 |
13:15 - 13:30 | |
13:30 - 13:45 | |
13:45 - 14:00 | |
14:00 - 14:15 | |
14:15 - 14:30 |
September 4, 2021
-
Daily wrap up07:45 - 08:00
-
Industry Symposium08:00 - 09:00
-
General Session 1:
Molecular Pathogenesis, Cell Biology and Translational Research09:00 - 10:00 -
Break10:00 - 10:15
-
Clinical State of the Art10:15 - 10:45
-
Break10:45 - 11:00
-
Best Clinical Poster session11:00 - 12:00
-
Break12:00 - 12:15
-
ILCA Tumor Board12:15 - 13:00
-
General Session 2:
Epidemiology, Staging and Prognosis13:00 - 14:30
September 4, 2021 | |
---|---|
19:45 - 20:00 | Daily wrap up 19:45 20:00 |
20:00 - 20:15 | Industry Symposium 20:00 21:00 |
20:15 - 20:30 | |
20:30 - 20:45 | |
20:45 - 21:00 | |
21:00 - 21:15 | General Session 1: Molecular Pathogenesis, Cell Biology and Translational Research 21:00 22:00 |
21:15 - 21:30 | |
21:30 - 21:45 | |
21:45 - 22:00 | |
22:00 - 22:15 | Break 22:00 22:15 |
22:15 - 22:30 | Clinical State of the Art 22:15 22:45 Clinical State of the Art Past, present, and future of transplant oncology - Vincenzo Mazaferro |
22:30 - 22:45 | |
22:45 - 23:00 | Break 22:45 23:00 |
23:00 - 23:15 | Best Clinical Poster session 23:00 00:00 |
23:15 - 23:30 | |
23:30 - 23:45 | |
23:45 - 00:00 | |
00:00 - 00:15 | Break 00:00 00:15 |
September 4, 2021
-
Daily wrap up19:45 - 20:00
-
Industry Symposium20:00 - 21:00
-
General Session 1:
Molecular Pathogenesis, Cell Biology and Translational Research21:00 - 22:00 -
Break22:00 - 22:15
-
Clinical State of the Art22:15 - 22:45
-
Break22:45 - 23:00
-
Best Clinical Poster session23:00 - 00:00
-
Break00:00 - 00:15
September 4, 2021 | |
---|---|
00:15 - 00:30 | ILCA Tumor Board 00:15 01:00 ILCA Tumor Board Chair: Pierre Nahon |
00:30 - 00:45 | |
00:45 - 01:00 | |
01:00 - 01:15 | General Session 2: Epidemiology, Staging and Prognosis 01:00 02:30 |
01:15 - 01:30 | |
01:30 - 01:45 | |
01:45 - 02:00 | |
02:00 - 02:15 | |
02:15 - 02:30 |
September 4, 2021
-
ILCA Tumor Board00:15 - 01:00
-
General Session 2:
Epidemiology, Staging and Prognosis01:00 - 02:30
Sunday September 5, 2021
September 5, 2021 | |
---|---|
13:45 - 14:00 | Daily wrap up 13:45 14:00 |
14:00 - 14:15 | Industry Symposium 14:00 15:00 |
14:15 - 14:30 | |
14:30 - 14:45 | |
14:45 - 15:00 | |
15:00 - 15:15 | General Session 3: Diagnosis, Imaging and Biomarkers 15:00 16:30 |
15:15 - 15:30 | |
15:30 - 15:45 | |
15:45 - 16:00 | |
16:00 - 16:15 | |
16:15 - 16:30 | |
16:30 - 16:45 | Break 16:30 16:45 |
16:45 - 17:00 | ILCA Debates 16:45 17:30 |
17:00 - 17:15 | |
17:15 - 17:30 | |
17:30 - 17:45 | Break 17:30 17:45 |
17:45 - 18:00 | Clinical Science Symposium: The future of combination therapies in HCC 17:45 18:45 |
18:00 - 18:15 | |
18:15 - 18:30 | |
18:30 - 18:45 | |
18:45 - 19:00 | Break 18:45 19:00 |
19:00 - 19:15 | General Session 4: Therapy & Miscellaneous & Clinical Trials in progress 19:00 20:30 |
19:15 - 19:30 | |
19:30 - 19:45 | |
19:45 - 20:00 | |
20:00 - 20:15 | |
20:15 - 20:30 | |
20:30 - 20:45 | Farewell Address 20:30 20:45 |
September 5, 2021
-
Daily wrap up13:45 - 14:00
-
Industry Symposium14:00 - 15:00
-
General Session 3:
Diagnosis, Imaging and Biomarkers15:00 - 16:30 -
Break16:30 - 16:45
-
ILCA Debates16:45 - 17:30
-
Break17:30 - 17:45
-
Clinical Science Symposium:
The future of combination therapies in HCC17:45 - 18:45 -
Break18:45 - 19:00
-
General Session 4:
Therapy & Miscellaneous & Clinical Trials in progress19:00 - 20:30 -
Farewell Address20:30 - 20:45
September 5, 2021 | |
---|---|
04:45 - 05:00 | Daily wrap up 04:45 05:00 |
05:00 - 05:15 | Industry Symposium 05:00 06:00 |
05:15 - 05:30 | |
05:30 - 05:45 | |
05:45 - 06:00 | |
06:00 - 06:15 | General Session 3: Diagnosis, Imaging and Biomarkers 06:00 07:30 |
06:15 - 06:30 | |
06:30 - 06:45 | |
06:45 - 07:00 | |
07:00 - 07:15 | |
07:15 - 07:30 | |
07:30 - 07:45 | Break 07:30 07:45 |
07:45 - 08:00 | ILCA Debates 07:45 08:30 |
08:00 - 08:15 | |
08:15 - 08:30 | |
08:30 - 08:45 | Break 08:30 08:45 |
08:45 - 09:00 | Clinical Science Symposium: The future of combination therapies in HCC 08:45 09:45 |
09:00 - 09:15 | |
09:15 - 09:30 | |
09:30 - 09:45 | |
09:45 - 10:00 | Break 09:45 10:00 |
10:00 - 10:15 | General Session 4: Therapy & Miscellaneous & Clinical Trials in progress 10:00 11:30 |
10:15 - 10:30 | |
10:30 - 10:45 | |
10:45 - 11:00 | |
11:00 - 11:15 | |
11:15 - 11:30 | |
11:30 - 11:45 | Farewell Address 11:30 11:45 |
September 5, 2021
-
Daily wrap up04:45 - 05:00
-
Industry Symposium05:00 - 06:00
-
General Session 3:
Diagnosis, Imaging and Biomarkers06:00 - 07:30 -
Break07:30 - 07:45
-
ILCA Debates07:45 - 08:30
-
Break08:30 - 08:45
-
Clinical Science Symposium:
The future of combination therapies in HCC08:45 - 09:45 -
Break09:45 - 10:00
-
General Session 4:
Therapy & Miscellaneous & Clinical Trials in progress10:00 - 11:30 -
Farewell Address11:30 - 11:45
September 5, 2021 | |
---|---|
07:45 - 08:00 | Daily wrap up 07:45 08:00 |
08:00 - 08:15 | Industry Symposium 08:00 09:00 |
08:15 - 08:30 | |
08:30 - 08:45 | |
08:45 - 09:00 | |
09:00 - 09:15 | General Session 3: Diagnosis, Imaging and Biomarkers 09:00 10:30 |
09:15 - 09:30 | |
09:30 - 09:45 | |
09:45 - 10:00 | |
10:00 - 10:15 | |
10:15 - 10:30 | |
10:30 - 10:45 | Break 10:30 10:45 |
10:45 - 11:00 | ILCA Debates 10:45 11:30 |
11:00 - 11:15 | |
11:15 - 11:30 | |
11:30 - 11:45 | Break 11:30 11:45 |
11:45 - 12:00 | Clinical Science Symposium: The future of combination therapies in HCC 11:45 12:45 |
12:00 - 12:15 | |
12:15 - 12:30 | |
12:30 - 12:45 | |
12:45 - 13:00 | Break 12:45 13:00 |
13:00 - 13:15 | General Session 4: Therapy & Miscellaneous & Clinical Trials in progress 13:00 14:30 |
13:15 - 13:30 | |
13:30 - 13:45 | |
13:45 - 14:00 | |
14:00 - 14:15 | |
14:15 - 14:30 | |
14:30 - 14:45 | Farewell Address 14:30 14:45 |
September 5, 2021
-
Daily wrap up07:45 - 08:00
-
Industry Symposium08:00 - 09:00
-
General Session 3:
Diagnosis, Imaging and Biomarkers09:00 - 10:30 -
Break10:30 - 10:45
-
ILCA Debates10:45 - 11:30
-
Break11:30 - 11:45
-
Clinical Science Symposium:
The future of combination therapies in HCC11:45 - 12:45 -
Break12:45 - 13:00
-
General Session 4:
Therapy & Miscellaneous & Clinical Trials in progress13:00 - 14:30 -
Farewell Address14:30 - 14:45
September 5, 2021 | |
---|---|
19:45 - 20:00 | Daily wrap up 19:45 20:00 |
20:00 - 20:15 | Industry Symposium 20:00 21:00 |
20:15 - 20:30 | |
20:30 - 20:45 | |
20:45 - 21:00 | |
21:00 - 21:15 | General Session 3: Diagnosis, Imaging and Biomarkers 21:00 22:30 |
21:15 - 21:30 | |
21:30 - 21:45 | |
21:45 - 22:00 | |
22:00 - 22:15 | |
22:15 - 22:30 | |
22:30 - 22:45 | Break 22:30 22:45 |
22:45 - 23:00 | ILCA Debates 22:45 23:30 |
23:00 - 23:15 | |
23:15 - 23:30 | |
23:30 - 23:45 | Break 23:30 23:45 |
23:45 - 00:00 | Clinical Science Symposium: The future of combination therapies in HCC 23:45 00:45 |
00:00 - 00:15 | |
00:15 - 00:30 | |
00:30 - 00:45 |
September 5, 2021
-
Daily wrap up19:45 - 20:00
-
Industry Symposium20:00 - 21:00
-
General Session 3:
Diagnosis, Imaging and Biomarkers21:00 - 22:30 -
Break22:30 - 22:45
-
ILCA Debates22:45 - 23:30
-
Break23:30 - 23:45
-
Clinical Science Symposium:
The future of combination therapies in HCC23:45 - 00:45
September 5, 2021 | |
---|---|
00:45 - 01:00 | Break 00:45 01:00 |
01:00 - 01:15 | General Session 4: Therapy & Miscellaneous & Clinical Trials in progress 01:00 02:30 |
01:15 - 01:30 | |
01:30 - 01:45 | |
01:45 - 02:00 | |
02:00 - 02:15 | |
02:15 - 02:30 | |
02:30 - 02:45 | Farewell Address 02:30 02:45 |
September 5, 2021
-
Break00:45 - 01:00
-
General Session 4:
Therapy & Miscellaneous & Clinical Trials in progress01:00 - 02:30 -
Farewell Address02:30 - 02:45